Pulse Biosciences grants stock options to director
PULSE BIOSCIENCES, INC. director Maria Sainz reported receiving two grants of stock options on June 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
PULSE BIOSCIENCES, INC. director Maria Sainz reported receiving two grants of stock options on June 11, 2026. The awards cover 3,793 and 30,000 options to buy common stock at an exercise price of $26.89 per share and expire on June 11, 2036.
According to the disclosures, 3,793 options vest in equal monthly installments over one year starting July 11, 2026, while 30,000 options vest in equal quarterly installments over one year starting September 5, 2026. These are compensation-related grants, not open‑market stock purchases or sales.
Insider Trade Summary
Grant/Award: 33,793 shares
Grant/Award
2 txns
Insider
Sainz Maria
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 30,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 3,793 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 33,793 contracts (Direct)
Footnotes (2)
- F1. The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026.
- F2. The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026.
Key Figures
Option grant 1 size: 3,793 options
Option grant 2 size: 30,000 options
Exercise price: $26.89 per share
+3 more
6 metrics
Option grant 1 size
3,793 options
Stock Option (right to buy) granted June 11, 2026
Option grant 2 size
30,000 options
Stock Option (right to buy) granted June 11, 2026
Exercise price
$26.89 per share
Conversion or exercise price for both option grants
Expiration date
June 11, 2036
Options expire if not exercised by this date
Monthly vesting start
July 11, 2026
First monthly vesting installment for 3,793-share grant
Quarterly vesting start
September 5, 2026
First quarterly vesting installment for 30,000-share grant
Key Terms
Stock Option (right to buy), exercise price, expiration date, vest in equal monthly installments, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 26.8900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-11T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest in equal monthly installments financial
"will vest in equal monthly installments over a one-year period"
vest in equal quarterly installments financial
"will vest in equal quarterly installments over a one-year period"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Pulse Biosciences (PLSE) disclose in this Form 4 for Maria Sainz?
Pulse Biosciences reported that director Maria Sainz received two grants of stock options on June 11, 2026. The awards are compensation-related and give her the right to buy company common stock in the future at a fixed exercise price.
How many stock options were granted to Maria Sainz at Pulse Biosciences (PLSE)?
Maria Sainz received two option grants: one covering 3,793 stock options and another covering 30,000 stock options. Each grant relates to Pulse Biosciences common stock and is documented as a derivative security with a right to buy shares at a set price.
What is the exercise price and expiration date of Maria Sainz’s options at PLSE?
Both option grants carry an exercise price of $26.89 per share and an expiration date of June 11, 2036. This means she can choose to buy Pulse Biosciences common stock at $26.89 any time before the options expire, subject to vesting.
How do the new Pulse Biosciences (PLSE) options for Maria Sainz vest?
The 3,793-share option grant vests in equal monthly installments over one year starting July 11, 2026. The 30,000-share grant vests in equal quarterly installments over one year starting September 5, 2026, contingent on her continued service at each vesting date.
Is Maria Sainz buying or selling Pulse Biosciences (PLSE) stock in this filing?
The filing shows no open‑market buying or selling of common stock by Maria Sainz. Instead, it reports compensation-related grants of stock options, classified as acquisitions of derivative securities rather than market transactions in existing shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates